JP2005533081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005533081A5 JP2005533081A5 JP2004516150A JP2004516150A JP2005533081A5 JP 2005533081 A5 JP2005533081 A5 JP 2005533081A5 JP 2004516150 A JP2004516150 A JP 2004516150A JP 2004516150 A JP2004516150 A JP 2004516150A JP 2005533081 A5 JP2005533081 A5 JP 2005533081A5
- Authority
- JP
- Japan
- Prior art keywords
- injectable depot
- depot composition
- polymer
- aromatic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 claims 36
- 239000003795 chemical substances by application Substances 0.000 claims 21
- 230000009286 beneficial effect Effects 0.000 claims 14
- 229920000642 polymer Polymers 0.000 claims 14
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims 11
- -1 Aromatic alcohols Chemical class 0.000 claims 8
- 150000002148 esters Chemical class 0.000 claims 8
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 7
- 239000002904 solvent Substances 0.000 claims 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical group CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 6
- 239000002245 particle Substances 0.000 claims 5
- 159000000032 aromatic acids Chemical class 0.000 claims 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims 4
- 229920001577 copolymer Polymers 0.000 claims 3
- 239000004310 lactic acid Substances 0.000 claims 3
- 235000014655 lactic acid Nutrition 0.000 claims 3
- 239000003607 modifier Substances 0.000 claims 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 2
- 125000005907 alkyl ester group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 229940035676 analgesics Drugs 0.000 claims 2
- 239000000730 antalgic agent Substances 0.000 claims 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 2
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 229940127219 anticoagulant drug Drugs 0.000 claims 2
- 239000000164 antipsychotic agent Substances 0.000 claims 2
- 235000019445 benzyl alcohol Nutrition 0.000 claims 2
- 229960002903 benzyl benzoate Drugs 0.000 claims 2
- 229920000249 biocompatible polymer Polymers 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 239000003205 fragrance Substances 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 239000003589 local anesthetic agent Substances 0.000 claims 2
- 229960005015 local anesthetics Drugs 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 229920002101 Chitin Polymers 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000003886 Glycoproteins Human genes 0.000 claims 1
- 108090000288 Glycoproteins Proteins 0.000 claims 1
- 102000004895 Lipoproteins Human genes 0.000 claims 1
- 108090001030 Lipoproteins Proteins 0.000 claims 1
- 102000011931 Nucleoproteins Human genes 0.000 claims 1
- 108010061100 Nucleoproteins Proteins 0.000 claims 1
- 229920002732 Polyanhydride Polymers 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 229920000954 Polyglycolide Polymers 0.000 claims 1
- 229920001710 Polyorthoester Polymers 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 230000002491 angiogenic effect Effects 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000003080 antimitotic agent Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 239000004067 bulking agent Substances 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 239000003527 fibrinolytic agent Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229920001308 poly(aminoacid) Polymers 0.000 claims 1
- 229920000747 poly(lactic acid) Polymers 0.000 claims 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims 1
- 229920000768 polyamine Polymers 0.000 claims 1
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 239000004417 polycarbonate Substances 0.000 claims 1
- 239000000622 polydioxanone Substances 0.000 claims 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920001855 polyketal Polymers 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 229920006324 polyoxymethylene Polymers 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 150000003890 succinate salts Chemical class 0.000 claims 1
- 229920001897 terpolymer Polymers 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39186702P | 2002-06-25 | 2002-06-25 | |
| PCT/US2003/019762 WO2004000269A1 (en) | 2002-06-25 | 2003-06-25 | Short duration depot formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010270394A Division JP5631708B2 (ja) | 2002-06-25 | 2010-12-03 | 短期間デポ調剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005533081A JP2005533081A (ja) | 2005-11-04 |
| JP2005533081A5 true JP2005533081A5 (https=) | 2006-06-29 |
Family
ID=30000765
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004516150A Withdrawn JP2005533081A (ja) | 2002-06-25 | 2003-06-25 | 短期間デポ調剤 |
| JP2010270394A Expired - Fee Related JP5631708B2 (ja) | 2002-06-25 | 2010-12-03 | 短期間デポ調剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010270394A Expired - Fee Related JP5631708B2 (ja) | 2002-06-25 | 2010-12-03 | 短期間デポ調剤 |
Country Status (20)
| Country | Link |
|---|---|
| EP (3) | EP2311431A1 (https=) |
| JP (2) | JP2005533081A (https=) |
| KR (1) | KR101172721B1 (https=) |
| CN (1) | CN1671357B (https=) |
| AR (1) | AR039729A1 (https=) |
| AU (1) | AU2003245643B2 (https=) |
| BR (1) | BR0312033A (https=) |
| CA (1) | CA2492047C (https=) |
| EC (1) | ECSP055566A (https=) |
| ES (1) | ES2530874T3 (https=) |
| IL (1) | IL165865A0 (https=) |
| MA (1) | MA27371A1 (https=) |
| MX (1) | MXPA05000199A (https=) |
| NO (1) | NO20050366L (https=) |
| NZ (1) | NZ574443A (https=) |
| PL (1) | PL207147B1 (https=) |
| RU (1) | RU2320321C2 (https=) |
| TW (1) | TWI353854B (https=) |
| WO (1) | WO2004000269A1 (https=) |
| ZA (1) | ZA200500677B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| ATE418323T1 (de) * | 2002-11-06 | 2009-01-15 | Alza Corp | Depot-formulierungen mit verzögerter freisetzung |
| US20050106214A1 (en) * | 2003-11-14 | 2005-05-19 | Guohua Chen | Excipients in drug delivery vehicles |
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| US8658210B2 (en) | 2006-04-17 | 2014-02-25 | Advanced Cardiovascular Systems, Inc. | Polyesteramide platform for site specific drug delivery |
| DK2167039T3 (en) | 2007-05-18 | 2017-01-09 | Durect Corp | Improved depot formulations |
| EP2152315B1 (en) | 2007-05-25 | 2016-01-06 | Indivior UK Limited | Sustained delivery formulations of risperidone compounds |
| US8846068B2 (en) * | 2008-04-18 | 2014-09-30 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising a local anesthetic |
| HUE047737T2 (hu) * | 2011-06-10 | 2020-05-28 | Ramscor Inc | Nyújtott hatóanyag-felszabadítású készítmények fehérjék szembe történõ bejuttatásához, és eljárás ezek elõállítására |
| US20140308352A1 (en) | 2013-03-11 | 2014-10-16 | Zogenix Inc. | Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material |
| HK1220628A1 (zh) | 2013-03-11 | 2017-05-12 | Durect Corporation | 包含高粘度液体载体的可注射控制释放组合物 |
| JP6564369B2 (ja) | 2013-12-09 | 2019-08-21 | デュレクト コーポレイション | 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法 |
| JP2023515918A (ja) | 2020-01-13 | 2023-04-17 | デュレクト コーポレーション | 不純物が低減された徐放性薬物送達システム及び関連の方法 |
| CN111388406B (zh) * | 2020-03-24 | 2024-02-23 | 西安力邦医药科技有限责任公司 | 氟维司群或其衍生物可注射递药贮库及其制备方法和应用 |
| CA3203561A1 (en) | 2021-01-12 | 2022-07-21 | Adrian Neil Verity | Sustained release drug delivery systems and related methods |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797492A (en) | 1972-12-27 | 1974-03-19 | Alza Corp | Device for dispensing product with directional guidance member |
| US3987790A (en) | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4443340A (en) | 1981-10-09 | 1984-04-17 | Betz Laboratories, Inc. | Control of iron induced fouling in water systems |
| US4985404A (en) | 1984-10-04 | 1991-01-15 | Monsanto Company | Prolonged release of biologically active polypeptides |
| US4865845A (en) | 1986-03-21 | 1989-09-12 | Alza Corporation | Release rate adjustment of osmotic or diffusional delivery devices |
| US4853218A (en) | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5085866A (en) | 1988-12-02 | 1992-02-04 | Southern Research Institute | Method of producing zero-order controlled-released devices |
| US5059423A (en) | 1988-12-13 | 1991-10-22 | Alza Corporation | Delivery system comprising biocompatible beneficial agent formulation |
| US5057318A (en) | 1988-12-13 | 1991-10-15 | Alza Corporation | Delivery system for beneficial agent over a broad range of rates |
| US5324519A (en) | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| US5112614A (en) | 1989-09-14 | 1992-05-12 | Alza Corporation | Implantable delivery dispenser |
| US5234693A (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
| US5234692A (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
| US5151093A (en) | 1990-10-29 | 1992-09-29 | Alza Corporation | Osmotically driven syringe with programmable agent delivery |
| US5620700A (en) | 1990-10-30 | 1997-04-15 | Alza Corporation | Injectable drug delivery system and method |
| GB9027422D0 (en) | 1990-12-18 | 1991-02-06 | Scras | Osmotically driven infusion device |
| US5137727A (en) | 1991-06-12 | 1992-08-11 | Alza Corporation | Delivery device providing beneficial agent stability |
| US5288214A (en) | 1991-09-30 | 1994-02-22 | Toshio Fukuda | Micropump |
| KR970007322B1 (ko) | 1991-12-19 | 1997-05-07 | 미쓰이도오아쓰 가가쿠 가부시키가이샤 | 폴리히드록시 카르복실산 및 그 제조방법 |
| CZ284045B6 (cs) * | 1991-12-27 | 1998-07-15 | Merck And Co., Inc. | Zařízení k řízenému uvolňování léčiva v disperzní formě a způsob výroby tohoto zařízení |
| US5308348A (en) | 1992-02-18 | 1994-05-03 | Alza Corporation | Delivery devices with pulsatile effect |
| US5456679A (en) | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect |
| US5209746A (en) | 1992-02-18 | 1993-05-11 | Alza Corporation | Osmotically driven delivery devices with pulsatile effect |
| US5656297A (en) | 1992-03-12 | 1997-08-12 | Alkermes Controlled Therapeutics, Incorporated | Modulated release from biocompatible polymers |
| GB9211268D0 (en) * | 1992-05-28 | 1992-07-15 | Ici Plc | Salts of basic peptides with carboxyterminated polyesters |
| US5242910A (en) | 1992-10-13 | 1993-09-07 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
| WO1994012158A1 (en) | 1992-12-02 | 1994-06-09 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
| US5556905A (en) | 1994-03-30 | 1996-09-17 | Reilly Industries, Inc. | Physically-modified degradable thermoplastic compositions |
| ATE317690T1 (de) | 1994-04-08 | 2006-03-15 | Qlt Usa Inc | Flüssige zusammensetzungen zur arzneistoffabgabe |
| US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| ATE203157T1 (de) * | 1996-12-20 | 2001-08-15 | Alza Corp | Injizierbare depotgelzubereitung und herstellungsverfahren |
| US6841617B2 (en) * | 2000-09-28 | 2005-01-11 | Battelle Memorial Institute | Thermogelling biodegradable aqueous polymer solution |
| PL351948A1 (en) * | 1999-06-04 | 2003-07-14 | Alza Corp | Implantable gel compositions and method of making thereof |
| JP2003525243A (ja) * | 2000-02-28 | 2003-08-26 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | 炎症性疾患の治療のための組成物及び方法 |
| WO2002000137A1 (en) | 2000-06-28 | 2002-01-03 | Shukla Atul J | Biodegradable vehicles and delivery systems of biologically active substances |
| EP1223513B1 (en) * | 2000-06-29 | 2011-08-10 | NTT DoCoMo, Inc. | Method and apparatus for setting communication parameter in information terminal |
| WO2002038185A2 (en) * | 2000-11-13 | 2002-05-16 | Atrix Laboratories, Inc. | Injectable sustained release delivery system with loperamide |
| DK1372729T3 (da) | 2001-02-23 | 2009-06-22 | Genentech Inc | Nedbrydelige polymere til injektion |
| KR20040058101A (ko) * | 2001-11-14 | 2004-07-03 | 알자 코포레이션 | 카테터 주입가능한 데포 조성물 및 그의 용도 |
| EP1446100B1 (en) * | 2001-11-14 | 2011-05-04 | Durect Corporation | Injectable depot compositions and uses thereof |
-
2003
- 2003-06-24 TW TW92117159A patent/TWI353854B/zh not_active IP Right Cessation
- 2003-06-24 AR ARP030102261 patent/AR039729A1/es not_active Application Discontinuation
- 2003-06-25 NZ NZ574443A patent/NZ574443A/en not_active IP Right Cessation
- 2003-06-25 PL PL373123A patent/PL207147B1/pl unknown
- 2003-06-25 CA CA2492047A patent/CA2492047C/en not_active Expired - Fee Related
- 2003-06-25 EP EP20100013179 patent/EP2311431A1/en not_active Withdrawn
- 2003-06-25 EP EP20030739271 patent/EP1515697B1/en not_active Expired - Lifetime
- 2003-06-25 ES ES03739271T patent/ES2530874T3/es not_active Expired - Lifetime
- 2003-06-25 RU RU2005101640A patent/RU2320321C2/ru not_active IP Right Cessation
- 2003-06-25 JP JP2004516150A patent/JP2005533081A/ja not_active Withdrawn
- 2003-06-25 KR KR20047021001A patent/KR101172721B1/ko not_active Expired - Fee Related
- 2003-06-25 IL IL16586503A patent/IL165865A0/xx unknown
- 2003-06-25 MX MXPA05000199A patent/MXPA05000199A/es active IP Right Grant
- 2003-06-25 EP EP20100013092 patent/EP2316421A1/en not_active Withdrawn
- 2003-06-25 AU AU2003245643A patent/AU2003245643B2/en not_active Ceased
- 2003-06-25 BR BR0312033A patent/BR0312033A/pt not_active Application Discontinuation
- 2003-06-25 CN CN038176122A patent/CN1671357B/zh not_active Expired - Fee Related
- 2003-06-25 WO PCT/US2003/019762 patent/WO2004000269A1/en not_active Ceased
-
2005
- 2005-01-24 ZA ZA200500677A patent/ZA200500677B/xx unknown
- 2005-01-24 MA MA28060A patent/MA27371A1/fr unknown
- 2005-01-24 NO NO20050366A patent/NO20050366L/no not_active Application Discontinuation
- 2005-01-24 EC ECSP055566 patent/ECSP055566A/es unknown
-
2010
- 2010-12-03 JP JP2010270394A patent/JP5631708B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005514349A5 (https=) | ||
| JP2005533081A5 (https=) | ||
| CA2466642A1 (en) | Injectable depot composition | |
| JP5737949B2 (ja) | 薬物制御送達用の非ポリマー組成物 | |
| CA2275525A1 (en) | Gel composition and methods | |
| ES2762460T3 (es) | Composiciones y métodos de administración dérmica | |
| AU767632B2 (en) | Microencapsulation and sustained release of biologically active agent | |
| AU687553B2 (en) | Process for the production of microparticles | |
| US6287588B1 (en) | Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof | |
| JP2006508127A5 (https=) | ||
| JP2011511088A5 (https=) | ||
| RU2010138739A (ru) | Лекарственные составы с контролируемым высвобождением, основанные на блок-сополимерах | |
| RU2320321C2 (ru) | Композиции депо кратковременного действия | |
| JP2005504797A5 (https=) | ||
| CY1109425T1 (el) | Φαρμακευτικες συνθεσεις για τη χορηγηση με ελεγχομενη αποδεσμευση βιολογικα δραστικων ενωσεων | |
| US9364518B2 (en) | Pharmaceutical composition containing goserelin for in-situ implant | |
| US20080095849A1 (en) | Peptide sustained release compositions and uses thereof | |
| JP2002537321A5 (https=) | ||
| ES2591352T3 (es) | Composición de tacrolimus estabilizada | |
| AU2007260739A1 (en) | Topical compositions | |
| KR20040042152A (ko) | 지속적 약물방출이 가능한 고분자 미립구 및 그 제조방법 | |
| CN1362883A (zh) | 包含表皮生长因子作为活性成分的稳定组合物 | |
| JP2009525975A (ja) | 多細胞生物の組織の治癒を促進するための組成物及びその方法 | |
| KR101699677B1 (ko) | 고나도트로핀을 위한 제제 | |
| US6207193B1 (en) | Transdermal drug delivery system |